Pendal Group LTD Aurinia Pharmaceuticals Inc. Transaction History

Pendal Group LTD

  • $12.2 Billion
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022
SELL
$10.05 - $22.48 $180,900 - $404,640
-18,000 Closed
0 $0
Q4 2021

Jan 18, 2022
BUY
$17.78 - $33.08 $142,240 - $264,640
8,000 Added 80.0%
18,000 $412,000
Q3 2021

Nov 05, 2021
BUY
$10.93 - $23.55 $109,300 - $235,500
10,000 New
10,000 $221,000

Others Institutions Holding AUPH

# of Institutions
207
Shares Held
58.6M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.28B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Pendal Group LTD Portfolio

Follow Pendal Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email